The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim results from the full population of the phase 3b CompLEEment-1 study of ribociclib (RIBO) plus letrozole (LET) in the treatment of HR+/HER2– advanced breast cancer (ABC).
 
Michelino DeLaurentiis
Honoraria - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - Eisai; Roche
 
Simona Borstnar
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; Novartis; Pfizer
Speakers' Bureau - Amgen; Krka; Lilly; Novartis; Pfizer
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Roche
 
Ellen Warner
No Relationships to Disclose
 
Salvador Bofill
No Relationships to Disclose
 
William Jacot
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; MSD; Novartis; Pfizer
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Susan Faye Dent
Honoraria - amgen; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; novartis; Pfizer; Roche Canada
 
Miguel Martin
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Novartis (Inst); Roche (Inst)
 
Alistair E. Ring
Consulting or Advisory Role - Genomic Health; Lilly; Novartis; Pfizer; Roche UK
 
Paul H. Cottu
Honoraria - AstraZeneca; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Lilly; Lilly; Novartis; pfizer; Roche
 
Janice M. Lu
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Genentech; Novartis; Pfizer; University of Southern California
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Eva Ciruelos
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Novartis; Pfizer; Roche
 
Hamdy A. Azim
Employment - Innate Pharma (I)
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Pfizer; Pfizer (Inst)
 
Sanjoy Chatterjee
Consulting or Advisory Role - Tata Medical Center (Inst)
 
Katie Zhou
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jiwen Wu
Employment - Novartis
 
Nii Ankrah
No Relationships to Disclose
 
Claudio Zamagni
Honoraria - Istituto Gentili; Pierre Fabre; Takeda; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Eisai; Lilly; Novartis; Pfizer; PharmaMar; QuintilesIMS; Roche; Tesaro
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Celgene (Inst); Medivation (Inst); Morphotek (Inst); Novartis (Inst); pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Seagen (Inst); Synthon (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Celgene; Istituto Gentili; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche; Tesaro